JP2012501181A - バイオマーカー・プロファイルを測定するためのシステムおよび方法 - Google Patents

バイオマーカー・プロファイルを測定するためのシステムおよび方法 Download PDF

Info

Publication number
JP2012501181A
JP2012501181A JP2011525187A JP2011525187A JP2012501181A JP 2012501181 A JP2012501181 A JP 2012501181A JP 2011525187 A JP2011525187 A JP 2011525187A JP 2011525187 A JP2011525187 A JP 2011525187A JP 2012501181 A JP2012501181 A JP 2012501181A
Authority
JP
Japan
Prior art keywords
biomarkers
disorder
biomarker
subjects
subject
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2011525187A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012501181A5 (enExample
Inventor
アントーニイェーフィク・イリーナ
タム・ジョーゼフ
アーティーミシン・ロマン
ジェラル・クリストフ・ペ・ジェ
ヴィスティセン・ヤン・バストホルム
Original Assignee
ハー・ルンドベック・アクチエゼルスカベット
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ハー・ルンドベック・アクチエゼルスカベット filed Critical ハー・ルンドベック・アクチエゼルスカベット
Publication of JP2012501181A publication Critical patent/JP2012501181A/ja
Publication of JP2012501181A5 publication Critical patent/JP2012501181A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
    • G16B40/20—Supervised data analysis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Medical Informatics (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Data Mining & Analysis (AREA)
  • Evolutionary Biology (AREA)
  • Databases & Information Systems (AREA)
  • Software Systems (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Theoretical Computer Science (AREA)
  • Public Health (AREA)
  • Pathology (AREA)
  • Evolutionary Computation (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Computer Vision & Pattern Recognition (AREA)
  • Bioethics (AREA)
  • Artificial Intelligence (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
JP2011525187A 2008-08-27 2009-08-27 バイオマーカー・プロファイルを測定するためのシステムおよび方法 Pending JP2012501181A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US9227008P 2008-08-27 2008-08-27
US61/092,270 2008-08-27
PCT/US2009/055144 WO2010025216A1 (en) 2008-08-27 2009-08-27 System and methods for measuring biomarker profiles

Publications (2)

Publication Number Publication Date
JP2012501181A true JP2012501181A (ja) 2012-01-19
JP2012501181A5 JP2012501181A5 (enExample) 2012-11-08

Family

ID=41721907

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011525187A Pending JP2012501181A (ja) 2008-08-27 2009-08-27 バイオマーカー・プロファイルを測定するためのシステムおよび方法

Country Status (10)

Country Link
US (1) US20110172501A1 (enExample)
EP (1) EP2318551A4 (enExample)
JP (1) JP2012501181A (enExample)
KR (1) KR20110057188A (enExample)
CN (1) CN102224256A (enExample)
AU (1) AU2009285766A1 (enExample)
BR (1) BRPI0914859A2 (enExample)
CA (1) CA2728171A1 (enExample)
EA (1) EA201071324A1 (enExample)
WO (1) WO2010025216A1 (enExample)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2013524237A (ja) * 2010-04-05 2013-06-17 アプライド・リサーチ・アソシエイツ，インコーポレーテッド レーザ誘起ブレークダウン分光のための認識アルゴリズムを形成するための方法
WO2019008987A1 (ja) * 2017-07-07 2019-01-10 パナソニックＩｐマネジメント株式会社 情報提供方法、情報処理システム、情報端末、及び情報処理方法
JP2020507746A (ja) * 2017-01-08 2020-03-12 ザ ヘンリー エム．ジャクソン ファンデーション フォー ザ アドバンスメント オブ ミリタリー メディシン，インコーポレーテッド 対象特有の菌血症転記を予測するための教師付き学習を使用するためのシステムおよび方法

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8676739B2 (en) 2010-11-11 2014-03-18 International Business Machines Corporation Determining a preferred node in a classification and regression tree for use in a predictive analysis
US9336302B1 (en) 2012-07-20 2016-05-10 Zuci Realty Llc Insight and algorithmic clustering for automated synthesis
KR101483284B1 (ko) * 2013-01-31 2015-01-15 한국과학기술원 질병 관련 단일염기다형성 조합 추출 방법, 질병 발생 위험도 예측 방법, 그리고 이를 이용한 질병 발생 위험도 예측 장치
US20160209428A1 (en) * 2013-08-21 2016-07-21 The Regents Of The University Of California Diagnostic and predictive metabolite patterns for disorders affecting the brain and nervous system
WO2022187670A1 (en) * 2021-03-05 2022-09-09 University Of North Texas Health Science Center At Fort Worth Personalized medicine approach for treating cognitive loss
JP6364488B2 (ja) 2013-11-26 2018-07-25 ユニバーシティー オブ ノース テキサス ヘルス サイエンス センター アット フォートワースＵｎｉｖｅｒｓｉｔｙ Ｏｆ Ｎｏｒｔｈ Ｔｅｘａｓ Ｈｅａｌｔｈ Ｓｃｉｅｎｃｅ Ｃｅｎｔｅｒ Ａｔ Ｆｏｒｔ Ｗｏｒｔｈ 認知欠損を治療するための個別化医療的手法
US9545227B2 (en) 2013-12-13 2017-01-17 Vital Connect, Inc. Sleep apnea syndrome (SAS) screening using wearable devices
JP6882776B2 (ja) * 2015-11-12 2021-06-02 国立大学法人九州大学 うつ病診断用バイオマーカー及びその使用
US11205103B2 (en) 2016-12-09 2021-12-21 The Research Foundation for the State University Semisupervised autoencoder for sentiment analysis
CN110546277B (zh) 2017-03-01 2024-06-11 豪夫迈·罗氏有限公司 用于癌症的诊断和治疗方法
TWI640018B (zh) * 2017-03-15 2018-11-01 長庚醫療財團法人林口長庚紀念醫院 Data integration method
MX389484B (es) * 2017-11-13 2025-03-20 The Multiple Myeloma Res Foundation Inc Base de datos, de datos moleculares, omicos, de inmunoterapia, metabolicos, epigeneticos y clinicos, integrados
CA3019970A1 (en) * 2018-10-05 2020-04-05 Fang Liu Methods for diagnosing or treating post-traumatic stress disorder, and compositions therefor
US11537888B2 (en) * 2019-05-15 2022-12-27 The Florida International University Board Of Trustees Systems and methods for predicting pain level
CN113210264B (zh) * 2021-05-19 2023-09-05 江苏鑫源烟草薄片有限公司 烟草杂物剔除方法及装置

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004208547A (ja) * 2002-12-27 2004-07-29 Hitachi Ltd うつ病の評価方法
US20050208519A1 (en) * 2004-03-12 2005-09-22 Genenews Inc. Biomarkers for diagnosing schizophrenia and bipolar disorder
JP2005312435A (ja) * 2004-03-29 2005-11-10 Kazuhito Rokutan うつ病の評価方法

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6190857B1 (en) * 1997-03-24 2001-02-20 Urocor, Inc. Diagnosis of disease state using MRNA profiles in peripheral leukocytes
US5958688A (en) * 1997-04-28 1999-09-28 The Trustees Of The University Of Pennsylvania Characterization of mRNA patterns in neurites and single cells for medical diagnosis and therapeutics
NO972006D0 (no) * 1997-04-30 1997-04-30 Forskningsparken I Aas As Ny metode for diagnose av sykdommer
US20070178475A1 (en) * 1998-09-17 2007-08-02 Nehls Michael C Novel human polynucleotides and polypeptides encoded thereby
WO2000040749A2 (en) * 1999-01-06 2000-07-13 Genenews Inc. Method for the detection of gene transcripts in blood and uses thereof
DE10019058A1 (de) * 2000-04-06 2001-12-20 Epigenomics Ag Detektion von Variationen des DNA-Methylierungsprofils
US7329489B2 (en) * 2000-04-14 2008-02-12 Matabolon, Inc. Methods for drug discovery, disease treatment, and diagnosis using metabolomics
ES2305234T3 (es) * 2001-02-27 2008-11-01 Blanchette Rockefeller Neurosciences Institute Diagnostico de la enfermedad de alzheimer basado en la fosforilacion de una proteina quinosa activada por mitogeno.
JP3771502B2 (ja) * 2002-02-14 2006-04-26 国立大学法人 新潟大学 精神分裂病により発現量が変化する遺伝子を規定する核酸を解析する方法
WO2004007762A2 (en) * 2002-07-11 2004-01-22 Novartis Ag Genes associated with schizophrenia, adhd and bipolar disorders
JP2004135667A (ja) * 2002-09-27 2004-05-13 Japan Science & Technology Agency 血液を用いた統合失調症の診断方法
US20040248286A1 (en) * 2003-03-21 2004-12-09 Christine Konradi Nucleic acid molecules that are differentially regulated in a bipolar disorder and uses thereof
WO2005020784A2 (en) * 2003-05-23 2005-03-10 Mount Sinai School Of Medicine Of New York University Surrogate cell gene expression signatures for evaluating the physical state of a subject
WO2004111270A2 (en) * 2003-06-13 2004-12-23 The Babraham Institute Differential gene expression in schizophrenia
US20050069936A1 (en) * 2003-09-26 2005-03-31 Cornelius Diamond Diagnostic markers of depression treatment and methods of use thereof
US20050209181A1 (en) * 2003-11-05 2005-09-22 Huda Akil Compositions and methods for diagnosing and treating mental disorders
CN101133157A (zh) * 2004-06-03 2008-02-27 阿什洛米克斯控股有限公司 诊断应激的药物和方法
ES2660765T3 (es) * 2004-06-21 2018-03-26 The Board Of Trustees Of The Leland Stanford Junior University Genes y rutas expresadas de forma diferencial en trastorno bipolar y/o trastorno depresivo mayor
US7736621B2 (en) * 2004-08-03 2010-06-15 Hypatia Ltd. Methods for gauging the effect of a depression treatment by determining the levels of beta-arrestin 1 and G-protein coupled receptor kinase 2
WO2006097244A2 (en) * 2005-03-17 2006-09-21 F. Hoffman-La Roche Ag Methods for assessing emphysema
US20070122395A1 (en) * 2005-10-06 2007-05-31 Vanderbilt University Genetic and pharmacological regulation of antidepressant-sensitive biogenic amine transporters through PKG/p38 map kinase
US7906281B2 (en) * 2005-10-07 2011-03-15 The Regents Of The University Of California Method to predict the response to lithium treatment
WO2007044094A1 (en) * 2005-10-11 2007-04-19 Blanchette Rockefeller Neurosciences Institute Alzheimer's disease-specific alterations of the erk1/erk2 phosphorylation ratio as alzheimer's disease-specific molecular biomarkers (adsmb)
US20080033598A1 (en) * 2006-03-23 2008-02-07 Hollingsworth Stephen A Materials management system and method
US20070292880A1 (en) * 2006-05-05 2007-12-20 Robert Philibert Compositions and methods for detecting predisposition to a substance use disorder or to a mental illness or syndrome
WO2007136797A1 (en) * 2006-05-18 2007-11-29 The Mclean Hospital Corporation Methods for diagnosis and prognosis of psychotic disorders
WO2008011046A2 (en) * 2006-07-17 2008-01-24 The H.Lee Moffitt Cancer And Research Institute, Inc. Computer systems and methods for selecting subjects for clinical trials
RU2473555C2 (ru) * 2006-12-19 2013-01-27 ДжинГоу, Инк. Новые способы функционального анализа большого количества экспериментальных данных и групп генов, идентифицированных из указанных данных
WO2008124428A1 (en) * 2007-04-03 2008-10-16 Indiana University Research And Technology Corporation Blood biomarkers for mood disorders
WO2008144371A1 (en) * 2007-05-16 2008-11-27 The Board Of Trustees Of The Leland Stanford Junior University Methods and compositions for diagnosing suicidal tendencies

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004208547A (ja) * 2002-12-27 2004-07-29 Hitachi Ltd うつ病の評価方法
US20050208519A1 (en) * 2004-03-12 2005-09-22 Genenews Inc. Biomarkers for diagnosing schizophrenia and bipolar disorder
JP2005312435A (ja) * 2004-03-29 2005-11-10 Kazuhito Rokutan うつ病の評価方法

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
JPN6012055039; 精神神経学雑誌　（２００６）　ｖｏｌ．１０８，　ｎｏ．６，　ｐ．６４２-６４５ *
JPN6014007882; Ａｍ．　Ｊ．　Ｐｓｙｃｈｉａｔｒｙ　（２００４）　ｖｏｌ．１６１，　ｎｏ．１１，　ｐ．２０６６-２０７２ *
JPN6014007885; Ｐｒｏｇ．　Ｎｅｕｒｏｐｓｙｃｈｏｐｈａｒｍａｃｏｌ．　Ｂｉｏｌ．　Ｐｓｙｃｈｉａｔｒｙ　（２００６）　ｖｏｌ．３０，　ｎｏ．５，　ｐ．８９９-９０５ *

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2013524237A (ja) * 2010-04-05 2013-06-17 アプライド・リサーチ・アソシエイツ，インコーポレーテッド レーザ誘起ブレークダウン分光のための認識アルゴリズムを形成するための方法
JP2020507746A (ja) * 2017-01-08 2020-03-12 ザ ヘンリー エム．ジャクソン ファンデーション フォー ザ アドバンスメント オブ ミリタリー メディシン，インコーポレーテッド 対象特有の菌血症転記を予測するための教師付き学習を使用するためのシステムおよび方法
JP7097370B2 (ja) 2017-01-08 2022-07-07 ザ ヘンリー エム．ジャクソン ファンデーション フォー ザ アドバンスメント オブ ミリタリー メディシン，インコーポレーテッド 対象特有の菌血症転記を予測するための教師付き学習を使用するためのシステムおよび方法
WO2019008987A1 (ja) * 2017-07-07 2019-01-10 パナソニックＩｐマネジメント株式会社 情報提供方法、情報処理システム、情報端末、及び情報処理方法
JPWO2019008987A1 (ja) * 2017-07-07 2020-05-07 パナソニックＩｐマネジメント株式会社 情報提供方法、情報処理システム、情報端末、及び情報処理方法
JP7170250B2 (ja) 2017-07-07 2022-11-14 パナソニックＩｐマネジメント株式会社 情報提供方法、情報処理システム、及び情報処理方法

Also Published As

Publication number Publication date
AU2009285766A1 (en) 2010-03-04
EP2318551A4 (en) 2012-10-24
KR20110057188A (ko) 2011-05-31
EA201071324A1 (ru) 2011-12-30
BRPI0914859A2 (pt) 2015-11-03
WO2010025216A1 (en) 2010-03-04
EP2318551A1 (en) 2011-05-11
WO2010025216A9 (en) 2010-11-18
CA2728171A1 (en) 2010-03-04
US20110172501A1 (en) 2011-07-14
CN102224256A (zh) 2011-10-19

Similar Documents

Publication Publication Date Title
JP2012501181A (ja) バイオマーカー・プロファイルを測定するためのシステムおよび方法
Als et al. Depression pathophysiology, risk prediction of recurrence and comorbid psychiatric disorders using genome-wide analyses
Beesley et al. The emerging landscape of health research based on biobanks linked to electronic health records: Existing resources, statistical challenges, and potential opportunities
EP2044431B1 (en) Computer systems and methods for selecting subjects for clinical trials
US7991557B2 (en) Computer system and methods for constructing biological classifiers and uses thereof
US8185367B2 (en) Systems and methods for reconstructing gene networks in segregating populations
Park et al. Assessment and diagnostic relevance of novel serum biomarkers for early decision of ST-elevation myocardial infarction
US8914240B2 (en) Method for determining coronary artery disease risk
JP2017512304A (ja) バイオマーカーシグネチャー法ならびにそのための装置およびキット
CN106103744A (zh) 用于预测脓毒症发作的设备、试剂盒和方法
CN120966978A (zh) 诊断和治疗急性呼吸系统感染的方法
Clelland et al. Utilization of never-medicated bipolar disorder patients towards development and validation of a peripheral biomarker profile
US20150100242A1 (en) Method, kit and array for biomarker validation and clinical use
JP2023518291A (ja) 循環遊離ｍＲＮＡプロファイリングアッセイを使用してアルツハイマー病のリスクを検出するシステムおよび方法
Zollars et al. Clinical application of a modular genomics technique in systemic lupus erythematosus: progress towards precision medicine
WO2024050541A1 (en) Systems and methods for diagnosing a disease or a condition
WO2016118662A1 (en) Identification of epigenetic biomarkers in the saliva of children with autism spectrum disorder
CA2571180A1 (en) Computer systems and methods for constructing biological classifiers and uses thereof
Simon Interpretation of genomic data: questions and answers
Garcia Data-driven Approaches to Explore Precision Medicine
HK1163186A (en) System and methods for measuring biomarker profiles
US20230230655A1 (en) Methods and systems for assessing fibrotic disease with deep learning
JP7108573B2 (ja) 慢性中耳炎のリスクを判定する方法
Buckley An Investigation into the Genetic and Bacterial Factors That Cause Irritable Bowel Syndrome and a Solution in the Form of a Targeted Next Generation Sequencing Compatible Gene Panel for the Disease
Liu et al. Cuproptosis Signature Would Reveal the Acute‐Remitting Pattern in Patients with Neuromyelitis Optica Spectrum Disorder

Legal Events

Date Code Title Description
RD03 Notification of appointment of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7423

Effective date: 20120209

RD04 Notification of resignation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7424

Effective date: 20120222

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20120824

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20120824

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20120924

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20140225

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20140812